Monoclonal antibody 3F8 can effect durable remission in neuroblastoma patients refractory to chemotherapy:a phase II trial.
Bibliographic Information
- Other Title
-
- Monoclonal antibody 3F8 can effect durable remissions in neuroblastoma patients refractory to chemotherapy: a phase II trial
Journal
-
- Prog.Clin.Biol.Res.
-
Prog.Clin.Biol.Res. 366 395-400, 1991
- Tweet
Details 詳細情報について
-
- CRID
- 1573105974055466368
-
- NII Article ID
- 10004790727
-
- Data Source
-
- CiNii Articles
- Crossref